Publications

Export 27 results:
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Goodman, Shaun G  [Clear All Filters]
2012
Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med. 2012;367(14):1297-309. Abstract
Gurbel PA, Erlinge D, Ohman ME, Neely B, Neely M, Goodman SG, et al. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. JAMA. 2012;308(17):1785-94. Abstract
Gurbel PA, Erlinge D, Ohman ME, Neely B, Neely M, Goodman SG, et al. Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization: The TRILOGY ACS Platelet Function Substudy. JAMA. 2012:1-10. Abstract
Czarnecki A, Welsh RC, Yan RT, DeYoung PJ, Gallo R, Rose B, et al. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE). Can J Cardiol. 2012;28(1):40-7. Abstract
Czarnecki A, Welsh RC, Yan RT, DeYoung PJ, Gallo R, Rose B, et al. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE). Can J Cardiol. 2012;28(1):40-7. Abstract
Singh SM, Goodman SG, Yan RT, Dery J-, Wong GC, Gallo R, et al. Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes. Am J Cardiol. 2012;109(3):332-6. Abstract
2011
Ali S, Goodman SG, Yan RT, Budaj A, Fox KA, Gore JM, et al. Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes. Am Heart J. 2011;161(5):878-85. Abstract
Jolly SS, Shenkman H, Brieger D, Fox KA, Yan AT, Eagle KA, et al. Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events. Heart. 2011;97(3):197-202. Abstract
Krimly A, Yan RT, Yan AT, DeYoung PJ, Gallo R, Steg G, et al. Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes. The Canadian journal of cardiology. 2011. Abstract
Elbarouni B, Ismaeil N, Yan RT, Fox KA, Connelly KA, Baer C, et al. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes. Am Heart J. 2011;162(2):347-355.e1. Abstract
2010
Elbarouni B, Elmanfud O, Yan RT, Fox KA, Kornder JM, Rose B, et al. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Am Heart J. 2010;160(3):420-7. Abstract
Sibbald M, Yan AT, Huang W, Fox KA, Gore JM, Steg PG, et al. Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2010;160(5):855-61. Abstract
Fox KA, Carruthers K, Steg PG, Avezum A, Granger CB, Montalescot G, et al. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events. Eur Heart J. 2010;31(6):667-75. Abstract
Spencer FA, Montalescot G, Fox KA, Goodman SG, Granger CB, Goldberg RJ, et al. Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. Eur Heart J. 2010;31(11):1328-36. Abstract
Elbarasi E, Goodman SG, Yan RT, Welsh RC, Kornder J, Wong GC, et al. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization. Am Heart J. 2010;159(1):40-6. Abstract
2009
Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, Dellborg M, et al. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial. Circulation. 2009;119(22):2877-85. Abstract
Bagnall AJ, Goodman SG, Fox KA, Yan RT, Gore JM, Cheema AN, et al. Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol. 2009;103(11):1530-6. Abstract
Steg PG, Fox KA, Eagle KA, Furman M, Van de Werf F, Montalescot G, et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J. 2009;30(3):321-9. Abstract
Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, et al. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J. 2009;158(2):193-201.e1. Abstract
Rao RV, Goodman SG, Yan RT, Spencer FA, Fox KA, DeYoung PJ, et al. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Am Heart J. 2009;157(4):642-50.e1. Abstract
Aragam KG, Tamhane UU, Kline-Rogers E, Li J, Fox KA, Goodman SG, et al. Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. PLoS ONE. 2009;4(11):e7947. Abstract
2008
Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. European heart journal. 2008;29:609-17. Abstract
2007
Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA, Granger CB, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA : the journal of the American Medical Association. 2007;297:1892-900. Abstract
Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation. 2007;116:2793-801. Abstract
Oliveira GB, Avezum A, Anderson FA, Budaj A, Dabbous OH, Goodman SG, et al. Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification. American heart journal. 2007;153:493-9. Abstract